Total Funding
$316M
Employee Range
1-10
TORL BioTherapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative antibody-based therapies aimed at enhancing the lives of cancer patients. By harnessing the power of targeted medicine, TORL strives to provide effective treatment options that address unmet medical needs in oncology.
TORL BioTherapeutics data powered by:
Share
TORL BioTherapeutics data powered by:
TORL BioTherapeuticsOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
TORL BioTherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
7th
In Culver City
Top 78%out of 9 startups
National Rank
Share
1,964th
In United States
Top 23%out of 8869 startups
Regional Rank
Share
2,057th
In North America
Top 22%out of 9671 startups
TORL BioTherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
3rd
In Culver City
Top 100%out of 3 startups
National Rank
Share
804th
In United States
Top 24%out of 3470 startups
Regional Rank
Share
832nd
In North America
Top 23%out of 3721 startups
rankings by:
TORL BioTherapeuticsSB Rank Evolution
Not enough data points to display the chart.
TORL BioTherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro